Rare diseases
Investigational molecules
Locations
Ul. Jana III Sobieskiego 9, 02-957 Warsaw, Poland
Instytut Psychiatrii I Neurologii in Warsaw, Poland specialises in clinical trials of conditions such as Bipolar I disorder, Narcolepsy, Major depression, Mania, and other specialisations. This site conducts important research.
Clinical research at this site is focused on cardiovascular disease, with a strong emphasis on preventing recurrent ischemic stroke in people who have recently had an acute non-cardioembolic stroke or a high-risk transient ischemic attack.
The research at the Warsaw-based clinic is centered on improving both protection against future stroke and the overall safety of treatment for patients at high vascular risk.
Clinical trials currently enrolling participants at this site.
Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients
PolandEfficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
PolandPolandPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
PolandPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
PolandStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
PolandStudy to evaluate the effect of omaveloxolone on mitochondrial function in patients with Friedreich's ataxia
PolandA study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania
PolandLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder
PolandStudy of trospium chloride and xanomeline tartrate (KarXT) for treatment of manic episodes in adults with bipolar I disorder
PolandStudy of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo
PolandLong-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
